Regencell Bioscience (RGC) Short Interest Ratio & Short Volume $13.18 +0.58 (+4.60%) As of 08/7/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Regencell Bioscience Short Interest DataRegencell Bioscience (RGC) has a short interest of 1.82 million shares, representing 9.57% of the float (the number of shares available for trading by the public). This marks a 47.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 727,471 shares to cover all short positions.Current Short Interest1,820,000 sharesPrevious Short Interest1,230,000 sharesChange Vs. Previous Month+47.97%Dollar Volume Sold Short$24.93 millionShort Interest Ratio0.6 Days to CoverLast Record DateJuly 15, 2025Float Size19,010,000 sharesShort Percent of Float9.57%Today's Trading Volume391,552 sharesAverage Trading Volume727,471 sharesToday's Volume Vs. Average54% Short Selling Regencell Bioscience? Sign up to receive the latest short interest report for Regencell Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGC Short Interest Over TimeRGC Days to Cover Over TimeRGC Percentage of Float Shorted Over Time Regencell Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20251,820,000 shares $24.93 million +48.0%9.6%0.6 $13.70 6/30/20251,230,000 shares $20.96 million +17.1%4.0%0.4 $17.04 6/15/20251,050,000 shares $0.00 +5,150.0%3.4%0.3 $0.00 RGC Short Interest - Frequently Asked Questions What is Regencell Bioscience's current short interest? Short interest is the volume of Regencell Bioscience shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 1,820,000 shares of RGC short. 9.57% of Regencell Bioscience's shares are currently sold short. Learn More on Regencell Bioscience's current short interest. What is a good short interest ratio for Regencell Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGC shares currently have a short interest ratio of 1.0. Learn More on Regencell Bioscience's short interest ratio. What is a good short interest percentage for Regencell Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.57% of Regencell Bioscience's floating shares are currently sold short. Is Regencell Bioscience's short interest increasing or decreasing? Regencell Bioscience saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,820,000 shares, an increase of 48.0% from the previous total of 1,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Regencell Bioscience's float size? Regencell Bioscience currently has issued a total of 494,490,000 shares. Some of Regencell Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regencell Bioscience currently has a public float of 19,010,000 shares. How does Regencell Bioscience's short interest compare to its competitors? 9.57% of Regencell Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Regencell Bioscience: BioNTech SE Sponsored ADR (2.55%), Insmed, Inc. (5.11%), Summit Therapeutics PLC (3.85%), Teva Pharmaceutical Industries Ltd. (4.66%), Genmab A/S Sponsored ADR (0.60%), Moderna, Inc. (19.34%), Dr. Reddy's Laboratories Ltd (1.46%), Qiagen N.V. (2.93%), Viatris Inc. (3.32%), Ascendis Pharma A/S (4.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Regencell Bioscience stock? Short selling RGC is an investing strategy that aims to generate trading profit from Regencell Bioscience as its price is falling. RGC shares are trading up $0.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regencell Bioscience? A short squeeze for Regencell Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGC, which in turn drives the price of the stock up even further. How often is Regencell Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGC, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies BioNTech Short Squeeze Insmed Short Squeeze Summit Therapeutics Short Squeeze Teva Pharmaceutical Industries Short Squeeze Genmab A/S Short Squeeze Moderna Short Squeeze Dr. Reddy's Laboratories Short Squeeze Qiagen Short Squeeze Viatris Short Squeeze Ascendis Pharma A/S Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regencell Bioscience Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Regencell Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.